InflaRx Historical Income Statement

IFRX Stock

USD 2.36 0.05 2.16%

Historical analysis of InflaRx NV income statement accounts such as Depreciation And Amortization of 342.2 K or Interest Expense of 33.8 K can show how well InflaRx NV performed in making a profits. Evaluating InflaRx NV income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of InflaRx NV's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining InflaRx NV latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether InflaRx NV is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.

About InflaRx Income Statement Analysis

InflaRx NV Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to InflaRx NV shareholders. The income statement also shows InflaRx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

InflaRx NV Income Statement Chart

At this time, InflaRx NV's Interest Income is fairly stable compared to the past year. Net Interest Income is likely to rise to about 3.5 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 342.2 K in 2024.

Selling General Administrative Other Operating Expenses Research Development Ebitda Total Operating Expenses Net Income Applicable To Common Shares

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of InflaRx NV. It is also known as InflaRx NV overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Net Income Applicable To Common Shares

The net income that remains after preferred dividends have been deducted, available to common shareholders.

Most accounts from InflaRx NV's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into InflaRx NV current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.At this time, InflaRx NV's Interest Income is fairly stable compared to the past year. Net Interest Income is likely to rise to about 3.5 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 342.2 K in 2024.

InflaRx NV income statement Correlations

	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Interest Income	Reconciled Depreciation	Selling And Marketing Expenses
Interest Income		0.0	-0.58	0.41	0.46	-0.52	-0.43	-0.51	0.45	-0.51	0.46	-0.48	0.56	-0.48	-0.1	0.79	0.34	-0.67
Depreciation And Amortization	0.0		-0.65	0.69	0.61	-0.6	-0.57	-0.58	0.66	-0.57	0.6	-0.61	0.27	-0.62	-0.25	0.5	0.79	-0.28
Interest Expense	-0.58	-0.65		-0.76	-0.75	0.76	0.72	0.76	-0.77	0.76	-0.75	0.71	-0.78	0.7	0.26	-0.82	-0.81	0.35
Selling General Administrative	0.41	0.69	-0.76		0.94	-0.93	-0.87	-0.93	0.97	-0.93	0.94	-0.9	0.72	-0.9	-0.22	0.85	0.83	-0.33
Other Operating Expenses	0.46	0.61	-0.75	0.94		-0.99	-0.98	-0.99	0.97	-0.99	1.0	-0.98	0.66	-0.97	-0.3	0.86	0.88	-0.31
Operating Income	-0.52	-0.6	0.76	-0.93	-0.99		0.98	1.0	-0.96	1.0	-0.99	0.99	-0.65	0.99	0.3	-0.9	-0.88	0.44
Net Income From Continuing Ops	-0.43	-0.57	0.72	-0.87	-0.98	0.98		0.97	-0.94	0.97	-0.98	0.98	-0.57	0.97	0.39	-0.81	-0.89	0.31
Ebit	-0.51	-0.58	0.76	-0.93	-0.99	1.0	0.97		-0.95	1.0	-0.99	0.98	-0.69	0.98	0.24	-0.9	-0.85	0.39
Research Development	0.45	0.66	-0.77	0.97	0.97	-0.96	-0.94	-0.95		-0.95	0.97	-0.95	0.65	-0.94	-0.42	0.86	0.91	-0.34
Ebitda	-0.51	-0.57	0.76	-0.93	-0.99	1.0	0.97	1.0	-0.95		-0.99	0.98	-0.69	0.98	0.23	-0.9	-0.85	0.39
Total Operating Expenses	0.46	0.6	-0.75	0.94	1.0	-0.99	-0.98	-0.99	0.97	-0.99		-0.98	0.66	-0.97	-0.3	0.86	0.88	-0.31
Income Before Tax	-0.48	-0.61	0.71	-0.9	-0.98	0.99	0.98	0.98	-0.95	0.98	-0.98		-0.56	1.0	0.35	-0.87	-0.89	0.45
Total Other Income Expense Net	0.56	0.27	-0.78	0.72	0.66	-0.65	-0.57	-0.69	0.65	-0.69	0.66	-0.56		-0.55	0.09	0.73	0.46	-0.16
Net Income	-0.48	-0.62	0.7	-0.9	-0.97	0.99	0.97	0.98	-0.94	0.98	-0.97	1.0	-0.55		0.32	-0.87	-0.88	0.47
Income Tax Expense	-0.1	-0.25	0.26	-0.22	-0.3	0.3	0.39	0.24	-0.42	0.23	-0.3	0.35	0.09	0.32		-0.2	-0.58	0.14
Net Interest Income	0.79	0.5	-0.82	0.85	0.86	-0.9	-0.81	-0.9	0.86	-0.9	0.86	-0.87	0.73	-0.87	-0.2		0.77	-0.63
Reconciled Depreciation	0.34	0.79	-0.81	0.83	0.88	-0.88	-0.89	-0.85	0.91	-0.85	0.88	-0.89	0.46	-0.88	-0.58	0.77		-0.35
Selling And Marketing Expenses	-0.67	-0.28	0.35	-0.33	-0.31	0.44	0.31	0.39	-0.34	0.39	-0.31	0.45	-0.16	0.47	0.14	-0.63	-0.35

Click cells to compare fundamentals

InflaRx NV Account Relationship Matchups

InflaRx NV income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Income	2.8M	887.7K	109.4K	608.7K	3.0M	3.2M
Depreciation And Amortization	(31.8K)	664.0K	696.1K	585.9K	567.8K	342.2K
Interest Expense	22.2K	26K	24.8K	45.3K	35.6K	33.8K
Selling General Administrative	12.5M	8.5M	12.0M	14.9M	14.2M	10.1M
Gross Profit	(661.2K)	(664.0K)	(696.1K)	(585.9K)	(469.2K)	(492.6K)
Other Operating Expenses	56.8M	33.9M	47.6M	32.2M	45.0M	34.6M
Operating Income	(56.8M)	(33.9M)	(47.6M)	(32.2M)	(44.9M)	(47.2M)
Net Income From Continuing Ops	(53.3M)	(34.0M)	(45.6M)	(29.5M)	(34.8M)	(36.5M)
Ebit	(56.8M)	(33.1M)	(47.6M)	(31.9M)	(42.6M)	(44.8M)
Research Development	44.6M	25.7M	35.7M	37.5M	41.0M	28.4M
Ebitda	(56.8M)	(32.5M)	(46.9M)	(31.3M)	(42.1M)	(44.2M)
Cost Of Revenue	661.2K	664.0K	696.1K	585.9K	532.3K	383.7K
Total Operating Expenses	56.8M	33.9M	47.6M	32.2M	44.4M	34.5M
Income Before Tax	(53.3M)	(34.0M)	(45.6M)	(29.5M)	(42.7M)	(44.8M)
Total Other Income Expense Net	3.5M	(40.8K)	2.0M	2.8M	2.2M	1.7M
Net Income Applicable To Common Shares	(29.8M)	(53.3M)	(34.0M)	(45.6M)	(41.1M)	(43.1M)
Net Income	(49.7M)	(34.0M)	(45.7M)	(27.0M)	(42.7M)	(44.8M)
Income Tax Expense	(3.5M)	26K	24.8K	(2.4M)	(1.0)	(0.95)
Net Interest Income	2.8M	735.7K	40.6K	311.0K	3.3M	3.5M
Reconciled Depreciation	663.2K	712.7K	669.4K	596.6K	580.5K	544.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

InflaRx Historical Income Statement

About InflaRx Income Statement Analysis

InflaRx NV Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Net Income Applicable To Common Shares

InflaRx NV income statement Correlations

InflaRx NV Account Relationship Matchups

High Positive Relationship

High Negative Relationship

InflaRx NV income statement Accounts

Also Currently Popular

Additional Tools for InflaRx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Interest Income	Discontinued Operations
Depreciation And Amortization	Interest Expense
Selling General Administrative	Total Revenue
Gross Profit	Other Operating Expenses
Preferred Stock And Other Adjustments	Operating Income
Net Income From Continuing Ops	Ebit
Research Development	Ebitda
Cost Of Revenue	Non Recurring
Total Operating Expenses	Effect Of Accounting Charges
Income Before Tax	Non Operating Income Net Other
Extraordinary Items	Total Other Income Expense Net
Net Income Applicable To Common Shares	Net Income
Income Tax Expense	Minority Interest
Other Items	Tax Provision
Net Interest Income	Reconciled Depreciation
Selling And Marketing Expenses

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax
Income Before Tax	+ 0.99	Operating Income

Total Operating Expenses	- 0.99	Ebitda
Total Operating Expenses	- 0.99	Ebit
Total Operating Expenses	- 0.99	Operating Income
Ebitda	- 0.99	Other Operating Expenses
Ebit	- 0.99	Other Operating Expenses
Operating Income	- 0.99	Other Operating Expenses